Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.026 | 0.7 |
mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.026 | 0.7 |
mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.7 |
mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |